Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Naoki Morimoto

Showing results (291-300 of 298) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 298 results.
Liver Cancer|February 12, 2024
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L TrialMasatoshi Kudo, Kazuomi Ueshima, Issei Saeki, et al.
Resuscitation|September 30, 2014
Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency roomYoshimasa Takeda, Takahisa Kawashima, Kazuya Kiyota, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 6, 2020
Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infectionYoshinari Takaoka, Kouichi Miura, Naoki Morimoto, et al.
Cancer Medicine|February 18, 2026
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular CarcinomaMasanori Inoue, Sadahisa Ogasawara, Kazuhisa Asahara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH StudyKazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
Investigational New Drugs|June 6, 2024
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)Kazufumi Kobayashi, Sadahisa Ogasawara, Ei Itobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 1, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort StudySatoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka, et al.
Liver Cancer|February 28, 2022
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular CarcinomaKazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi, et al.
Pageof 30

Showing results (291-300 of 298) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 298 results.
Liver Cancer|February 12, 2024
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L TrialMasatoshi Kudo, Kazuomi Ueshima, Issei Saeki, et al.
Resuscitation|September 30, 2014
Feasibility study of immediate pharyngeal cooling initiation in cardiac arrest patients after arrival at the emergency roomYoshimasa Takeda, Takahisa Kawashima, Kazuya Kiyota, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 6, 2020
Real-world efficacy and safety of 12-week sofosbuvir/velpatasvir treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus infectionYoshinari Takaoka, Kouichi Miura, Naoki Morimoto, et al.
Cancer Medicine|February 18, 2026
Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular CarcinomaMasanori Inoue, Sadahisa Ogasawara, Kazuhisa Asahara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2023
A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden: The LAUNCH StudyKazufumi Kobayashi, Sadahisa Ogasawara, Susumu Maruta, et al.
Investigational New Drugs|June 6, 2024
Ramucirumab for advanced hepatocellular carcinoma in the current real world: a Japanese single-arm study post-REACH-2 (The R-evolution study)Kazufumi Kobayashi, Sadahisa Ogasawara, Ei Itobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|April 1, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort StudySatoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka, et al.
Liver Cancer|February 28, 2022
Evolution of Survival Impact of Molecular Target Agents in Patients with Advanced Hepatocellular CarcinomaKazufumi Kobayashi, Sadahisa Ogasawara, Aya Takahashi, et al.
Pageof 30